EL MONTE, Calif., April 11, 2024--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent" or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its first quarter 2024 financial results before the market opens on Friday, May 3, 2024. Management will host a conference call for the investment community the same day at 8:30 AM ET (5:30 AM PT) to discuss the results and answer questions.
Fulgent Genetics, Inc. ( NASDAQ:FLGT ) shareholders might be concerned after seeing the share price drop 25% in the...
Key Insights The projected fair value for Fulgent Genetics is US$33.29 based on 2 Stage Free Cash Flow to Equity...